You have no items in your shopping cart.
Cart summary
Item 1 of 3
Item 1 of 3
Siglec-2/CD22 Antibody (MMAE)
Catalog Number: orb1805460
| Catalog Number | orb1805460 |
|---|---|
| Category | Antibodies |
| Description | Anti-Siglec-2 / CD22 Reference Antibodyand Monomethyl auristatin E (MMAE) used for the study of hematological malignancies. |
| Target | Siglec-2 / CD22 |
| Clonality | Recombinant |
| Conjugation | MMAE |
| Reactivity | Human |
| Concentration | 1 mg/mL |
| Buffer/Preservatives | 100 mM Proline/Acetic acid 20mM Arginine pH 5.0 |
| Purity | > 95% |
| Purification | Protein A |
| UniProt ID | P20273 |
| MW | 151.97 kDa |
| Tested applications | ELISA, FA, FACS, In vivo |
| Antibody Type | Recombinant Antibody |
| Expression System | CHO |
| Endotoxins | < 0.001 EU/ug |
| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
| Note | For research use only |
Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab vedotin) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.
The purity of Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab vedotin)is more than 95% ;determined by SEC-HPLC.
Immobilized human Siglec 2 / CD22; His Tag at 2 μg/mL can bind Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab vedotin);EC50=0.008851μg/mL.
- Item 1 of 2
Anti-Siglec-2 / CD22 Reference Antibody (inotuzumab-MMAE) [orb1818400]
ELISA, FC
Human
Monoclonal
Unconjugated
100 μg - Item 1 of 2
Siglec-2/CD22 Antibody (MMAE) [orb1805424]
ELISA, FA, FACS, In vivo
Human
Recombinant
MMAE
100 μg, 1 mg 
